Hedgehog pathway inhibitors against tumor microenvironment

S Gampala, JY Yang - Cells, 2021 - mdpi.com
Targeting the hedgehog (HH) pathway to treat aggressive cancers of the brain, breast,
pancreas, and prostate has been ongoing for decades. Gli gene amplifications have been …

Updates on management of adult medulloblastoma

N Majd, M Penas-Prado - Current treatment options in oncology, 2019 - Springer
Opinion statement Medulloblastoma (MB) is a malignant embryonal tumor of the posterior
fossa and is the most common type of brain cancer in pediatric patients. In contrast, adult MB …

Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse

U Herrlinger*, A Steinbrecher*, J Rieger, P Hau… - Journal of …, 2005 - Springer
Adult medulloblastoma is a rare tumor with few retrospective studies published so far. The
role of adjuvant chemotherapy or chemotherapy at relapse is unclear. This study reports …

New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology

AA Brandes, M Bartolotti, G Marucci… - Critical reviews in …, 2015 - Elsevier
Medulloblastoma is the most common central nervous system tumor in children, while it is
extremely rare in adults. Multimodal treatment involving surgery, radiotherapy and …

Survival of adults treated for medulloblastoma using paediatric protocols

F Spreafico, M Massimino, L Gandola, G Cefalo… - European Journal of …, 2005 - Elsevier
We retrospectively studied 26 consecutive adults treated for medulloblastoma using
paediatric protocols. Between 1987 and 2003, patients⩾ 18 years old were given adjuvant …

No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma

M Massimino, L Gandola, F Spreafico… - International Journal of …, 2009 - Elsevier
PURPOSE: Myeloablative regimens were frequently used for medulloblastoma relapsing
after craniospinal irradiation (CSI): in 1997–2002, we used repeated surgery, standard-dose …

High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of …

D Valteau-Couanet, B Fillipini, E Benhamou… - Bone marrow …, 2005 - nature.com
We previously demonstrated that Busulfan–Thiotepa (Bu–Thio) and ASCT effectively treated
patients with locally relapsed medulloblastoma after surgery and conventional …

Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET

F Saran, BG Baumert, AL Creak… - Pediatric blood & …, 2008 - Wiley Online Library
Purpose To evaluate the efficacy and toxicity of hypofractionated stereotactic radiotherapy in
the management of locally recurrent or residual central nervous system (CNS) primitive …

High‐dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system

P Gill, M Litzow, J Buckner, C Arndt… - … Journal of the …, 2008 - Wiley Online Library
BACKGROUND Embryonal central nervous system (CNS) tumors (medulloblastoma,
cerebral neuroblastoma, pineoblastoma, and primitive neuroectodermal tumors) are rare in …

Three‐year recurrence‐free survival in a patient with recurrent medulloblastoma after resection, high‐dose chemotherapy, and intrathecal Yttrium‐90‐labeled DOTA0‐D‐Phe1 …

D Beutler, P Avoledo, JC Reubi, HR Mäcke… - Cancer, 2005 - Wiley Online Library
BACKGROUND Most medulloblastomas express high levels of somatostatin type 2
receptors (sst2). DOTA0‐D‐Phe1‐Tyr3‐octreotide (DOTATOC) specifically binds sst2 in the …